The effects of acyl chain length on the micelle properties of poly(ethylene oxide)-block-poly(N-hexylL-aspartamide)-acyl conjugates

Derivatives of poly(ethylene oxide)-block-poly(β-benzyl-aspartate), 12 :25 have been prepared via aminolysis of the benzyl protecting group with 6-amino-1-hexanol, followed by subsequent acylation with acetic anhydride, hexanoic acid, lauric acid, or stearic acid. A series of amphiphilic diblock copolymers based on poly(ethylene oxide)-block-poly(N-hexyl-aspartamide)-acyl conjugates with various acyl chain lengths have been prepared. The extent of esterification was determined by 1H-NMR. Aqueous micelle solutions were prepared by a dialysis method and the polymer series was characterized as a function of the acyl chain length. Transmission electron microscopy and dynamic light scattering revealed micelle-like structures of nanoscopic dimensions (< 100 nm). Environmentally sensitive fluorescent probes were loaded into the micelles in order to study the properties of the hydrophobic microdomain and to determine the critical micelle concentration (CMC). Steady-state fluorescence measurements indicated that the relative apparent core viscosity and polarity are modulated by the relative length of the attached acyl chains, as is the CMC. Increasing the acyl chain length results in a decreased CMC and a more viscous and less polar core region. Carefully chosen chemical moieties can be introduced in order to influence the properties of the poly(L-Asp) blocks of the micelles. As a result, the micellar properties can be altered via chemical modification in order to impact several key properties relevant to drug delivery.

[1]  G. Kwon,et al.  The effect of alkyl core structure on micellar properties of poly(ethylene oxide)-block-poly(L-aspartamide) derivatives. , 2001, Colloids and surfaces. B, Biointerfaces.

[2]  Guojun Liu,et al.  Poly(solketal methacrylate)-block-poly(2-cinnamoyloxyethyl methacrylate)-block-poly(allyl methacrylate): Synthesis and Micelle Formation , 2001 .

[3]  G. Kwon,et al.  Micelles of poly(ethylene oxide)-block-poly(N-alkyl stearate L-aspartamide): synthetic analogues of lipoproteins for drug delivery. , 2000, Journal of biomedical materials research.

[4]  Glen S. Kwon,et al.  Methotrexate Esters of Poly(Ethylene Oxide)-Block-Poly(2-Hydroxyethyl-L-Aspartamide). Part I: Effects of the Level of Methotrexate Conjugation on the Stability of Micelles and on Drug Release , 2000, Pharmaceutical Research.

[5]  Y. M. Lee,et al.  Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres. II. Thermo-responsive drug release behaviors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Y. Nagasaki,et al.  Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(D,L-lactide) block copolymers as potential drug carrier. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Christine Allen,et al.  Nano-engineering block copolymer aggregates for drug delivery , 1999 .

[8]  G. Kwon,et al.  Micelle-like structures of poly(ethylene oxide)-block-poly(2-hydroxyethyl aspartamide)-methotrexate conjugates , 1999 .

[9]  T. Okano,et al.  Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[10]  T. Okano,et al.  Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[11]  A. Eisenberg,et al.  Morphogenic Effect of Solvent on Crew-Cut Aggregates of Apmphiphilic Diblock Copolymers , 1998 .

[12]  F. Winnik,et al.  Fluorescence methods in the study of the interactions of surfactants with polymers , 1996 .

[13]  Markus Antonietti,et al.  Micellization of strongly segregated block copolymers , 1996 .

[14]  Leaf Huang,et al.  Effects of Polyethyleneglycol Chain Length and Phospholipid Acyl Chain Composition on the Interaction of Polyethyleneglycol-phospholipid Conjugates with Phospholipid: Implications in Liposomal Drug Delivery , 1996, Pharmaceutical Research.

[15]  P. Wisian-Neilson,et al.  Modification of poly(methylphenylphosphazene) to increase hydrophobicity , 1994 .

[16]  Teruo Okano,et al.  Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-Adriamycin conjugates , 1994 .

[17]  T. Okano,et al.  Micelles based on AB block copolymers of poly(ethylene oxide) and poly(.beta.-benzyl L-aspartate) , 1993 .

[18]  T. Okano,et al.  Preparation of micelle-forming polymer-drug conjugates. , 1992, Bioconjugate chemistry.

[19]  T. A. Hatton,et al.  Solubilization of polycyclic aromatic hydrocarbons by poly(ethylene oxide-propylene oxide) block copolymer micelles: effects of polymer structure , 1992 .

[20]  M. Winnik,et al.  The Py scale of solvent polarities , 1984 .

[21]  D. Georgescauld,et al.  INTRAMOLECULAR EXCIMER FLUORESCENCE: A NEW PROBE OF PHASE TRANSITIONS IN SYNTHETIC PHOSPHOLIPID MEMBRANES , 1980 .

[22]  J. K. Thomas,et al.  Environmental effects on vibronic band intensities in pyrene monomer fluorescence and their application in studies of micellar systems , 1977 .

[23]  Teruo Okano,et al.  Preparation and Characterization of the Micelle-Forming Polymeric Drug Indomethacin-lncorporated Polyfethylene oxide)-Poly(β-benzyl L-aspartate) Block Copolymer Micelles , 1996 .